James Zhang, MD
Advanced Heart Failure and Transplant Cardiology · Seattle, WANPI 1467816041
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (45.8%), food and beverage and education — rather than concentrated in one kind of arrangement. Abbott accounts for 87.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $1,327 and has fallen 81.8% since, to $241 in 2025. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in WA, where the typical reported total is $3,028.
Across 26 payments — averaging $111.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- AstraZeneca$125
- Medtronic$60
- Amgen$52
- Pfizer$35
- Inari Medical, Inc.$34
- plus $70 from 3 others
What the payments were for
- Travel & lodging$1,32946%
- Food & beverage$1,24543%
- Education$32611%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 17 | $2,525 |
| AstraZeneca | 1 | $125 |
| Medtronic | 1 | $60 |
| Amgen | 2 | $52 |
| Pfizer | 1 | $35 |
| Inari Medical, Inc. | 1 | $34 |
| Boston Scientific | 1 | $29 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $25 |
| Teleflex LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CARDIOMEMS$1,663
- ENSITE$326
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$181
- FARXIGA$125
How this compares
$2,901 in reported general payments places this provider in the 45th percentile of 20 advanced heart failure and transplant cardiology providers in Washington.
See all advanced heart failure and transplant cardiology providers in Washington →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Seattle
- Wayne LevySeattle$275K
- John MignoneSeattle$19K
- Preethi PirlamarlaSeattle$14K
- Salpy PamboukianSeattle$5K
- April Stempien OteroSeattle$2K
- Sunu ThomasSeattle$2K
- Richard ChengSeattle$759
- Elina MinamiSeattle$698
- Daniel FishbeinSeattle$600
- Kevin ObrienSeattle$222
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.